JPWO2023127918A5 - - Google Patents

Info

Publication number
JPWO2023127918A5
JPWO2023127918A5 JP2023571077A JP2023571077A JPWO2023127918A5 JP WO2023127918 A5 JPWO2023127918 A5 JP WO2023127918A5 JP 2023571077 A JP2023571077 A JP 2023571077A JP 2023571077 A JP2023571077 A JP 2023571077A JP WO2023127918 A5 JPWO2023127918 A5 JP WO2023127918A5
Authority
JP
Japan
Prior art keywords
formula
compound
solution containing
nucleic acid
defined above
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023571077A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023127918A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/048385 external-priority patent/WO2023127918A1/ja
Publication of JPWO2023127918A1 publication Critical patent/JPWO2023127918A1/ja
Publication of JPWO2023127918A5 publication Critical patent/JPWO2023127918A5/ja
Pending legal-status Critical Current

Links

JP2023571077A 2021-12-27 2022-12-27 Pending JPWO2023127918A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021212132 2021-12-27
PCT/JP2022/048385 WO2023127918A1 (ja) 2021-12-27 2022-12-27 オリゴ核酸化合物の製造方法

Publications (2)

Publication Number Publication Date
JPWO2023127918A1 JPWO2023127918A1 (cg-RX-API-DMAC7.html) 2023-07-06
JPWO2023127918A5 true JPWO2023127918A5 (cg-RX-API-DMAC7.html) 2025-07-28

Family

ID=86999200

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023571077A Pending JPWO2023127918A1 (cg-RX-API-DMAC7.html) 2021-12-27 2022-12-27

Country Status (8)

Country Link
US (1) US20250066396A1 (cg-RX-API-DMAC7.html)
EP (1) EP4458833A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023127918A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240129006A (cg-RX-API-DMAC7.html)
CN (1) CN118488959A (cg-RX-API-DMAC7.html)
AU (1) AU2022424485A1 (cg-RX-API-DMAC7.html)
CA (1) CA3244382A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023127918A1 (cg-RX-API-DMAC7.html)

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE312834T1 (de) 1989-12-20 2005-12-15 Avi Biopharma Inc Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten
AU5752601A (en) 2000-05-04 2001-11-12 Avi Biopharma Inc Splice-region antisense composition and method
ES2627917T3 (es) 2004-06-28 2017-08-01 The University Of Western Australia Oligonucleótidos no codificantes para la inducción de la omisión exónica y métodos de uso de los mismos
US7790694B2 (en) 2005-07-13 2010-09-07 Avi Biopharma Inc. Antisense antibacterial method and compound
MX2010004955A (es) 2007-11-15 2010-06-30 Avi Biopharma Inc Metodo de sintesis de oligomeros de morfolina.
EP3133160B1 (en) 2008-10-24 2018-12-12 Sarepta Therapeutics, Inc. Exon skipping compositions for dmd
SI2607484T1 (sl) 2008-10-27 2016-11-30 Biomarin Technologies B.V. Metode in sredstva za učinkovito preskakovanje eksona 45 v pre-mRNA Duchennove mišične distrofije
HUE040445T2 (hu) 2009-11-12 2019-03-28 Univ Western Australia Antiszensz molekulák és eljárások betegségek kezelésére
TWI541024B (zh) 2010-09-01 2016-07-11 日本新藥股份有限公司 反義核酸
CN103154009B (zh) * 2010-09-30 2015-06-10 日本新药株式会社 吗啉基核酸衍生物
CN108588073A (zh) 2011-12-28 2018-09-28 日本新药株式会社 反义核酸
IN2014DN06768A (cg-RX-API-DMAC7.html) 2012-02-17 2015-05-22 Ajinomoto Kk
US10214555B2 (en) 2012-11-14 2019-02-26 Takeda Pharmaceutical Company Limitjed Method for liquid-phase synthesis of nucleic acid
EP3760720A1 (en) 2013-03-14 2021-01-06 Sarepta Therapeutics, Inc. Exon skipping compositions for treating muscular dystrophy
HK1220154A1 (zh) 2013-03-15 2017-04-28 Sarepta Therapeutics, Inc. 改进的用於治疗肌营养不良的组合物
JP6477464B2 (ja) * 2013-05-24 2019-03-06 味の素株式会社 モルフォリノオリゴヌクレオチドの製造方法
BR112016020618B1 (pt) 2014-03-12 2023-04-04 Nippon Shinyaku Co., Ltd. Oligômero antissentido, composição farmacêutica, e, uso de um oligômero antissentido
PT3159409T (pt) 2014-06-17 2020-01-21 Nippon Shinyaku Co Ltd Ácido nucleico anti-sentido para utilização no tratamento da distrofia muscular de duchenne
HUE050061T2 (hu) 2015-09-15 2020-12-28 Nippon Shinyaku Co Ltd Antiszensz nukleinsav
US11560401B2 (en) * 2018-05-10 2023-01-24 Nippon Shinyaku Co., Ltd. Method for preparing oligonucleic acid compound
JP6770553B2 (ja) * 2018-07-20 2020-10-14 藤本化学製品株式会社 アルコキシフェニル誘導体、ヌクレオシド保護体およびヌクレオチド保護体、オリゴヌクレオチド製造方法、ならびに、置換基除去方法
EP4059944A4 (en) * 2019-11-13 2024-04-10 Nippon Shinyaku Co., Ltd. METHOD FOR PREPARING AN OLIGONUCLICE ACID COMPOUND
EP4059943A4 (en) * 2019-11-13 2024-01-31 Nippon Shinyaku Co., Ltd. METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND
IL294271A (en) 2019-12-26 2022-08-01 Nippon Shinyaku Co Ltd Antisense nucleic acid that induces skipping of exon 50
PE20230237A1 (es) 2020-02-28 2023-02-07 Nippon Shinyaku Co Ltd Acidos nucleicos antisentido que inducen la omision del exon 51
CN117279926A (zh) * 2021-04-28 2023-12-22 日本新药株式会社 低聚核酸化合物的制造方法

Similar Documents

Publication Publication Date Title
JP4945129B2 (ja) フルオラス担体およびそれを用いたオリゴヌクレオチド誘導体の製造方法
ES2745504T3 (es) Acidos nucleicos peptídicos gamma que contienen miniPEG preorganizados conformacionalmente
JP5548852B2 (ja) 疎水性基結合ヌクレオシド、疎水性基結合ヌクレオシド溶液、及び疎水性基結合オリゴヌクレオチド合成方法
KR102504759B1 (ko) 포스포로디아미데이트 모르폴리노 올리고머의 제조 방법
CN109563114B (zh) 用于制备寡聚物的方法
KR102523522B1 (ko) 포스포로디아미데이트 모르폴리노 올리고머의 제조 방법
JP3675847B2 (ja) ヌクレオチド又はオリゴヌクレオチドホスホロアミダイトの合成方法
TWI848981B (zh) 新穎亞磷醯胺、及髮夾型單股rna分子之製造方法
KR102523527B1 (ko) 포스포로디아미데이트 모르폴리노 올리고머의 제조 방법
CN115335387A (zh) 核酸寡聚物的制造方法
JP6537338B2 (ja) 核酸固相合成用リンカー及び担体
JP2022183382A (ja) 改善されたイメテルスタットの調製方法
JP2021522806A (ja) 光活性化された作用物質を使用してポリヌクレオチドアレイを合成する方法
JP7475056B2 (ja) 光応答性ヌクレオチドアナログの製造方法
JP7298866B2 (ja) 核酸合成用固相担体及びそれを用いた核酸の製造方法
JP5808025B2 (ja) アミノ化オリゴヌクレオチド用固相担体
JP6429264B2 (ja) ボラノホスフェート化合物、及び核酸オリゴマー
WO2007013190A1 (ja) オリゴヌクレオチドプローブ
CN118488959A (zh) 低聚核酸化合物的制造方法
RU2787350C1 (ru) Способ получения морфолиновых олигомеров
HK40113683A (en) Method for producing oligonucleic acid compound
HK40108064A (en) Method for producing oligonucleic acid compound